{"id":"NCT03200912","sponsor":"Actavis Inc.","briefTitle":"An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis","officialTitle":"A Multicenter Randomized Doubleblind Vehicle-controlled Parallel Comparison Study to Determine Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.015% and Picato® Gel 0.015% in Subjects With Actinic Keratosis on the Face or Scalp","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-08-19","primaryCompletion":"2017-03-07","completion":"2017-03-22","firstPosted":"2017-06-27","resultsPosted":"2020-01-14","lastUpdate":"2020-01-14"},"enrollment":507,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["ACTINIC KERATOSIS"],"interventions":[{"type":"DRUG","name":"Ingenol Mebutate (Picato®)","otherNames":["RLD"]},{"type":"DRUG","name":"Generic Ingenol Mebutate","otherNames":["Test"]},{"type":"DRUG","name":"Vehicle Foam","otherNames":["Placebo"]}],"arms":[{"label":"Picato","type":"ACTIVE_COMPARATOR"},{"label":"Generic Ingenol Mebutate","type":"EXPERIMENTAL"},{"label":"Vehicle Foam","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this study was to evaluate the safety and therapeutic equivalence of generic ingenol mebutate gel, 0.015% to Picato gel, 0.015% by establishing the therapeutic comparability of the two active products and the superiority of the two active products over the vehicle gel in the treatment of AK on the face and scalp.","primaryOutcome":{"measure":"Complete Clearance of AK Lesions","timeFrame":"57 days","effectByArm":[{"arm":"Generic Ingenol Mebutate","deltaMin":45,"sd":null},{"arm":"Picato (Ingenol Mebutate)","deltaMin":44,"sd":null},{"arm":"Vehicle Gel","deltaMin":7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":21},"locations":{"siteCount":23,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":170},"commonTop":["Nasopharyngitis","Application site pain","Upper respiratory tract infection","Application site pruritus","Headache"]}}